[Skip to Content]
[Skip to Content Landing]
March 7, 2012

Prescription Drug Monitoring Programs

Author Affiliations

Author Affiliations: Stanford University School of Medicine, Stanford, California (Mr Yokell) (myokell@Stanford.edu); and Warren Alpert Medical School of Brown University, Providence, Rhode Island (Drs Green and Rich).

JAMA. 2012;307(9):912-913. doi:10.1001/jama.307.9.912-b

To the Editor: The Commentary by Drs Gugelmann and Perrone1 highlights the important role of prescription monitoring programs in the struggle against opioid misuse in the United States. Although the authors emphasized the uncertain efficacy of these programs in reducing opioid-related morbidity and mortality, we believe there are additional applications for these programs and alternate ways to assess their overall effect.